Dual antiplatelet therapy in acute ischemic stroke: Does diabetes mellitus define a target population?

Neurotherapeutics · Published 2026-04-01 · DOI 10.1016/j.neurot.2026.e00907

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.neurot.2026.e00907

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial · Neurotherapeutics · 2026 · Same journal
• PrPC modulates BACE1-dependent amyloid pathology under chronic cerebral hypoperfusion: Implications for vascular cognitive impairment · Neurotherapeutics · 2026 · Same journal
• Drug repurposing opportunities across 92 CNS-related conditions using deep learning and whole-genome sequencing · Neurotherapeutics · 2026 · Same journal
• Identifying treatment-responsive patient subgroups in a neutral clinical trial of Intensive blood pressure reduction in acute intracerebral hemorrhage: A post hoc explainable machine learning analysis · Neurotherapeutics · 2026 · Same journal
• Electric muscle stimulation attenuates neuroinflammation and improves the outcome of acute ischemic stroke in mice · Neurotherapeutics · 2026 · Same journal
• Bilateral intermittent theta burst stimulation over the primary motor cortex improves motor and affective symptoms via thalamic network reintegration in mid-stage Parkinson's disease · Neurotherapeutics · 2026 · Same journal
• Sex-specific considerations in migraine therapy · Neurotherapeutics · 2026 · Same journal
• PEBP1 inhibition as a therapeutic target for neurological recovery in ischemic stroke · Neurotherapeutics · 2026 · Same journal
• Hemodynamics Beyond Ischemic Zone Underlies Early Neurological Deterioration in Minor Stroke with Large Vessel Occlusion · Neurotherapeutics · 2026 · Same journal
• α6GABAA receptor-selective positive allosteric modulator as a novel therapy for fibromyalgia: A proof-of-concept study in mice modeling chronic widespread musculoskeletal pain · Neurotherapeutics · 2026 · Same journal